Please use this identifier to cite or link to this item:
http://repository.kln.ac.lk/handle/123456789/24412
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ranawaka, U.K. | |
dc.date.accessioned | 2022-02-10T04:14:58Z | |
dc.date.available | 2022-02-10T04:14:58Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Clinical Medicine (Lond.). 2022; 22(1):18-20. | en_US |
dc.identifier.issn | 1470-2118 | |
dc.identifier.uri | http://repository.kln.ac.lk/handle/123456789/24412 | |
dc.description | Indexed in MEDLINE. | en_US |
dc.description.abstract | A large majority of neurological infections remain undiagnosed worldwide. Emerging and re-emerging infections are likely to be responsible for a significant proportion of these. Over the last two decades, several new organisms producing neurological infection and the neurotropic potential of many other known pathogens have been identified. Large outbreaks caused by re-emerging pathogens such as Chikungunya virus, Zika virus and Ebola virus have led to better delineation of their neurological manifestations. Recognition of the pandemic potential of emerging pathogens and an improved understanding of their host-vector-environment interactions would help us be better prepared to meet these emerging threats. | en_US |
dc.language.iso | en | en_US |
dc.publisher | The Royal College of Physicians of London | en_US |
dc.subject | emerging infections | en_US |
dc.subject | neurological infections | en_US |
dc.subject | tropical infections | en_US |
dc.title | Emerging tropical neurological infections | en_US |
dc.type | Article | en_US |
Appears in Collections: | Journal/Magazine Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
clinmed-22-1-18.pdf | 89.7 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.